SARS CoV 2 News and Research

RSS

New studies indicate the presence of cerebrovascular-neurological dysfunction in COVID-19 patients

As the SARS-CoV-2 virus, or COVID-19 has unfurled its tentacles across the globe, the severe respiratory and pulmonary disorders associated with the infection have become well known.

22 Jul 2020

Study shows chloroquine does not prevent SARS-CoV-2

More than 600,000 people worldwide have fallen victim to the lung disease COVID-19 so far, which is caused by the SARS coronavirus-2 (SARS-CoV-2).

22 Jul 2020

Scientists isolate potent SARS-CoV-2 neutralizing antibodies from COVID-19 patients

Researchers at Columbia University Irving Medical Center have isolated antibodies from several COVID-19 patients that, to date, are among the most potent in neutralizing the SARS-CoV-2 virus.

22 Jul 2020

Vitamin D could help suppress excessive T cell-mediated lung inflammation in severe COVID-19

As COVID-19 continues to spread over the world scientists continue to seek the reasons for the difference in disease severity from person to person.

22 Jul 2020

GlobalData: Sample pooling-based COVID-19 test could reduce time and resources

Following the news that Quest Diagnostics received emergency use authorization from the Food and Drug Administration (FDA) for its sample pooling-based COVID-19 test;

22 Jul 2020

Faster identification and isolation of infected individuals reduce viral transmission

A new analysis of SARS-CoV-2 transmission data in China shows that faster identification and isolation of infected, symptomatic individuals contributed to the shortening of the average serial interval - or the period between the onset of symptoms in successive cases - over time, as fewer opportunities occurred for viral transmission from one infector to more individuals.

22 Jul 2020

Scientists report two new cryo-EM structures of SARS-Cov-2 spike protein

Scientists report two new cryo-EM structures representing the pre- and postfusion conformations of the full-length SARS-CoV-2 spike (S) protein, an essential viral component responsible for host cell entry and the spread of infection.

22 Jul 2020

Study: Race and ethnicity did not affect pregnancy and birth outcomes in women with COVID-19

Race and ethnicity did not affect pregnancy and birth outcomes in women with SARS-CoV-2 infection who gave birth at two hospitals in northern Manhattan during the height of the pandemic in New York City, according to a preliminary report from researchers at Columbia University Irving Medical Center and NewYork-Presbyterian.

22 Jul 2020

Study captures unexpected features of SARS-Cov-2 spike protein

The rod-like spike proteins on the surface of SARS CoV-2 are the tip of the spear of the COVID-19 pandemic.

22 Jul 2020

LabVantage COVID-19 LIMS solution implemented for onsite workplace health and safety

LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, today announced that a Fortune 100 global consumer packaged goods company has deployed the LabVantage COVID-19 LIMS solution to ensure employee health and safety in the workplace.

From LabVantage Solutions 22 Jul 2020

A new sign of COVID-19: a rash in the mouth

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has wreaked havoc across the globe, with more than 14.89 million people infected. Coronavirus disease (COVID-19), caused by SARS-CoV-2, has a string of symptoms that include cough, fever, and difficulty of breathing. As the disease evolved, many patients reported the loss of smell and taste as other accompanying symptoms.

21 Jul 2020

Research focuses on detection of COVID-19 airborne droplets using bioengineered membrane

Detection and analysis of airborne coronavirus droplets using a bioengineered membrane is the focus of exploratory research at the University of Maine and University of Massachusetts Amherst, funded by the National Science Foundation.

21 Jul 2020

Lab-made virus infects cells, interacts with antibodies just like SARS-CoV-2

Airborne and potentially deadly, the virus that causes COVID-19 can only be studied safely under high-level biosafety conditions.

21 Jul 2020

Autopsies reveal unexpected changes in the hearts of COVID-19 patients

A series of autopsies conducted by LSU Health New Orleans pathologists shows the damage to the hearts of COVID-19 patients is not the expected typical inflammation of the heart muscle associated with myocarditis, but rather a unique pattern of cell death in scattered individual heart muscle cells.

21 Jul 2020

Mouse model of fatal COVID-19 developed for vaccine and drug testing

Now, a new study published on the preprint server bioRxiv in July 2020 presents an engineered transgenic mouse that reproduces the functional and clinical characteristics of severe human SARS-CoV-2 infection.

21 Jul 2020

Breastfeeding support for new mothers during the COVID-19 pandemic

As the COVID-19 pandemic grips the world, concerns about transmission of the highly infectious causative agent – severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - from mother to the baby are valid.

21 Jul 2020

Pfizer/BioNTech COVID-19 vaccine elicits both neutralizing antibodies and T cell response

A new study published on the preprint server medRxiv by a research group from the U.S. and Germany indicates that a novel BNT162b1 RNA-based vaccine against coronavirus disease (COVID-19) induces functional and proinflammatory T cell responses in almost all participants – marking another landmark achievement for this promising vaccine candidate.

21 Jul 2020

SARS CoV 2 News and Research

New studies indicate the presence of cerebrovascular-neurological dysfunction in COVID-19 patients

Study shows chloroquine does not prevent SARS-CoV-2

Scientists isolate potent SARS-CoV-2 neutralizing antibodies from COVID-19 patients

Vitamin D could help suppress excessive T cell-mediated lung inflammation in severe COVID-19

GlobalData: Sample pooling-based COVID-19 test could reduce time and resources

Faster identification and isolation of infected individuals reduce viral transmission

Scientists report two new cryo-EM structures of SARS-Cov-2 spike protein

Study: Race and ethnicity did not affect pregnancy and birth outcomes in women with COVID-19

Study captures unexpected features of SARS-Cov-2 spike protein

LabVantage COVID-19 LIMS solution implemented for onsite workplace health and safety

A new sign of COVID-19: a rash in the mouth

Research focuses on detection of COVID-19 airborne droplets using bioengineered membrane

Lab-made virus infects cells, interacts with antibodies just like SARS-CoV-2

Autopsies reveal unexpected changes in the hearts of COVID-19 patients

Mouse model of fatal COVID-19 developed for vaccine and drug testing

Breastfeeding support for new mothers during the COVID-19 pandemic

Pfizer/BioNTech COVID-19 vaccine elicits both neutralizing antibodies and T cell response

Nitric oxide treatment can be pivotal in the fight against COVID-19

Sanford Burnham Prebys receives CIRM award to advance promising drug candidates for COVID-19

New tools developed to test the ability of anti-coronavirus antibodies

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News